Current status:
Cancelled Post Market
Current status date:
2005-12-06
Product name:
PACLITAXEL INJECTION
DIN:
02231605
Electronic product monograph is not available
Company:
IMMUNEX CORPORATION
One Amgen Centre Drive
Thousand Oaks
California
United States
91320-1799
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
PRESCRIPTION
Anatomical Therapeutic Chemical (ATC):
See footnote 4
L01CD01 PACLITAXEL
List of active ingredient(s)
|
Active ingredient(s)
See footnote8
|
Strength |
|
PACLITAXEL
|
6 MG / ML
|